
Sign up to save your podcasts
Or


As the treatment landscape continues to evolve, what do we need to know about current treatment challenges and novel therapeutic options? Dr. Hector Chapa is joined by Dr. Sandra Misale to explore emerging therapies in HER2-mutated non-small cell lung cancer.
By ReachMD4.5
22 ratings
As the treatment landscape continues to evolve, what do we need to know about current treatment challenges and novel therapeutic options? Dr. Hector Chapa is joined by Dr. Sandra Misale to explore emerging therapies in HER2-mutated non-small cell lung cancer.

39 Listeners

10 Listeners

59 Listeners

1,145 Listeners

195 Listeners

45 Listeners

7 Listeners